TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma

BACKGROUND: At present, there are a variety of antiviral drugs for HBV in clinical practice, but there is no standard scheme for transcatheter arterial chemoembolization(TACE) combined with antiviral drugs. The aim of this study was to investigate whether TACE must be combined with antiviral therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Haohao, Zheng, Chuansheng, Xiong, Bin, Xia, Xiangwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009967/
https://www.ncbi.nlm.nih.gov/pubmed/36915044
http://dx.doi.org/10.1186/s12885-023-10694-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009967/
https://www.ncbi.nlm.nih.gov/pubmed/36915044
http://dx.doi.org/10.1186/s12885-023-10694-9

Ejemplares similares